| Literature DB >> 26820575 |
Basudev Chowdhury1,2, Arun Seetharam3, Zhiping Wang4,5, Yunlong Liu4,5, Amy C Lossie2,6, Jyothi Thimmapuram3, Joseph Irudayaraj2,7.
Abstract
Cells alter their gene expression in response to exposure to various environmental changes. Epigenetic mechanisms such as DNA methylation are believed to regulate the alterations in gene expression patterns. In vitro and in vivo studies have documented changes in cellular proliferation, cytoskeletal remodeling, signal transduction, bone mineralization and immune deficiency under the influence of microgravity conditions experienced in space. However microgravity induced changes in the epigenome have not been well characterized. In this study we have used Next-generation Sequencing (NGS) to profile ground-based "simulated" microgravity induced changes on DNA methylation (5-methylcytosine or 5mC), hydroxymethylation (5-hydroxymethylcytosine or 5hmC), and simultaneous gene expression in cultured human lymphoblastoid cells. Our results indicate that simulated microgravity induced alterations in the methylome (~60% of the differentially methylated regions or DMRs are hypomethylated and ~92% of the differentially hydroxymethylated regions or DHMRs are hyperhydroxymethylated). Simulated microgravity also induced differential expression in 370 transcripts that were associated with crucial biological processes such as oxidative stress response, carbohydrate metabolism and regulation of transcription. While we were not able to obtain any global trend correlating the changes of methylation/ hydroxylation with gene expression, we have been able to profile the simulated microgravity induced changes of 5mC over some of the differentially expressed genes that includes five genes undergoing differential methylation over their promoters and twenty five genes undergoing differential methylation over their gene-bodies. To the best of our knowledge, this is the first NGS-based study to profile epigenomic patterns induced by short time exposure of simulated microgravity and we believe that our findings can be a valuable resource for future explorations.Entities:
Mesh:
Year: 2016 PMID: 26820575 PMCID: PMC4731572 DOI: 10.1371/journal.pone.0147514
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
List of hypermethylated DMRs located within +/- 1500 of Transcription Start Sites of genes.
Columns display the genomic coordinates of DMRs, Gene Symbol of the corresponding gene, the description of the genome and the exact distance in bp.
| DMR (Chr:Start-End) | Gene Symbol | Description | Distance |
|---|---|---|---|
| 2:74407290–74407690 | MOB1A | MOB kinase activator 1A | -1495 |
| 1:32620788–32621188 | KPNA6 | karyopherin alpha 6 (importin alpha 7) | -1475 |
| 8:48919307–48919707 | UBE2V2 | ubiquitin-conjugating enzyme E2 variant 2 | -1453 |
| 20:10644375–10644775 | JAG1 | jagged 1 | -1421 |
| 19:8526792–8527192 | HNRNPM | heterogeneous nuclear ribonucleoprotein M | -1389 |
| 10:103579850–103580250 | MGEA5 | meningioma expressed antigen 5 (hyaluronidase) | -1354 |
| 1:176177694–176178094 | RFWD2 | ring finger and WD repeat domain 2, E3 ubiquitin protein ligase | -1265 |
| 8:66547493–66547893 | ARMC1 | armadillo repeat containing 1 | -1251 |
| 17:73976545–73976945 | ACOX1 | acyl-CoA oxidase 1, palmitoyl | -1230 |
| 5:137912163–137912563 | HSPA9 | heat shock 70kDa protein 9 (mortalin) | -1230 |
| 1:9710401–9710801 | PIK3CD | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta | -1189 |
| 17:76820294–76820694 | USP36 | ubiquitin specific peptidase 36 | -1163 |
| 7:144108260–144108660 | NOBOX | NOBOX oogenesis homeobox | -1140 |
| 1:179333515–179333915 | AXDND1 | axonemal dynein light chain domain containing 1 | -1140 |
| 7:150781644–150782044 | AGAP3 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 | -1110 |
| 3:27765104–27765504 | EOMES | eomesodermin | -1098 |
| 1:27096449–27096849 | ARID1A | AT rich interactive domain 1A (SWI-like) | -1071 |
| 17:37608338–37608738 | MED1 | mediator complex subunit 1 | -999 |
| 4:94748859–94749259 | ATOH1 | atonal homolog 1 (Drosophila) | -983 |
| 10:111968848–111969248 | MXI1 | MAX interactor 1, dimerization protein | -941 |
| 20:35488994–35489394 | SOGA1 | suppressor of glucose, autophagy associated 1 | -918 |
| 22:51067323–51067723 | ARSA | arylsulfatase A | -916 |
| 10:112630503–112630903 | PDCD4 | programmed cell death 4 (neoplastic transformation inhibitor) | -862 |
| 16:75468037–75468437 | CFDP1 | craniofacial development protein 1 | -854 |
| 17:4235771–4236171 | UBE2G1 | ubiquitin-conjugating enzyme E2G 1 | -753 |
| 17:47492799–47493199 | PHB | prohibitin | -753 |
| 3:99978894–99979294 | TBC1D23 | TBC1 domain family, member 23 | -750 |
| 17:33469869–33470269 | NLE1 | notchless homolog 1 (Drosophila) | -735 |
| 17:65026584–65026984 | AC005544.1 | Uncharacterized protein | -725 |
| 2:88895888–88896288 | EIF2AK3 | eukaryotic translation initiation factor 2-alpha kinase 3 | -713 |
| 1:150265379–150265779 | MRPS21 | mitochondrial ribosomal protein S21 | -710 |
| 4:37827346–37827746 | PGM2 | phosphoglucomutase 2 | -709 |
| 20:42573450–42573850 | TOX2 | TOX high mobility group box family member 2 | -695 |
| 1:151738242–151738642 | OAZ3 | ornithine decarboxylase antizyme 3 | -689 |
| 11:33277352–33277752 | HIPK3 | homeodomain interacting protein kinase 3 | -666 |
| 15:60691398–60691798 | ANXA2 | annexin A2 | -657 |
| 17:3716988–3717388 | C17orf85 | chromosome 17 open reading frame 85 | -644 |
| 10:8095826–8096226 | GATA3 | GATA binding protein 3 | -630 |
| 9:123295232–123295632 | CDK5RAP2 | CDK5 regulatory subunit associated protein 2 | -599 |
| 7:48019521–48019921 | HUS1 | HUS1 checkpoint homolog (S. pombe) | -571 |
| 12:120109292–120109692 | PRKAB1 | protein kinase, AMP-activated, beta 1 non-catalytic subunit | -557 |
| 15:43637360–43637760 | ADAL | adenosine deaminase-like | -545 |
| 5:122180427–122180827 | SNX24 | sorting nexin 24 | -517 |
| 3:113676612–113677012 | ZDHHC23 | zinc finger, DHHC-type containing 23 | -489 |
| 19:58400668–58401068 | ZNF814 | zinc finger protein 814 | -463 |
| 14:93184061–93184461 | LGMN | legumain | -457 |
| 20:45280352–45280752 | SLC13A3 | solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 | -454 |
| 2:8977951–8978351 | KIDINS220 | kinase D-interacting substrate, 220kDa | -391 |
| 20:30639472–30639872 | HCK | hemopoietic cell kinase | -319 |
| 5:67521976–67522376 | PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | -286 |
| 16:25027042–25027442 | ARHGAP17 | Rho GTPase activating protein 17 | -255 |
| 19:11306249–11306649 | KANK2 | KN motif and ankyrin repeat domains 2 | -88 |
| 12:110783800–110784200 | ATP2A2 | ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 | -6 |
| 13:78493694–78494094 | EDNRB | endothelin receptor type B | 9 |
| 13:111839015–111839415 | ARHGEF7 | Rho guanine nucleotide exchange factor (GEF) 7 | 14 |
| 3:180633094–180633494 | FXR1 | fragile X mental retardation, autosomal homolog 1 | 46 |
| 12:122457270–122457670 | BCL7A | B-cell CLL/lymphoma 7A | 142 |
| 14:95569392–95569792 | DICER1 | dicer 1, ribonuclease type III | 175 |
| 3:64253200–64253600 | PRICKLE2 | prickle homolog 2 (Drosophila) | 255 |
| 19:45445601–45446001 | APOC4 | apolipoprotein C-IV | 270 |
| 13:114549584–114549984 | GAS6 | growth arrest-specific 6 | 272 |
| 5:68470171–68470571 | CCNB1 | cyclin B1 | 287 |
| 4:89079332–89079732 | ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 | 291 |
| 22:41257564–41257964 | DNAJB7 | DnaJ (Hsp40) homolog, subfamily B, member 7 | 366 |
| 15:83676793–83677193 | C15orf40 | chromosome 15 open reading frame 40 | 375 |
| 13:113301551–113301951 | C13orf35 | chromosome 13 open reading frame 35 | 393 |
| 9:130340673–130341073 | FAM129B | family with sequence similarity 129, member B | 395 |
| 21:34804877–34805277 | IFNGR2 | interferon gamma receptor 2 (interferon gamma transducer 1) | 451 |
| 12:70728471–70728871 | CNOT2 | CCR4-NOT transcription complex, subunit 2 | 456 |
| 4:80993052–80993452 | ANTXR2 | anthrax toxin receptor 2 | 465 |
| 19:58741108–58741508 | ZNF544 | zinc finger protein 544 | 474 |
| 11:85565301–85565701 | AP000974.1 | CDNA FLJ26432 fis, clone KDN01418; Uncharacterized protein | 485 |
| 19:40831600–40832000 | C19orf47 | chromosome 19 open reading frame 47 | 530 |
| 5:137070955–137071355 | KLHL3 | kelch-like family member 3 | 549 |
| 19:10120383–10120783 | COL5A3 | collagen, type V, alpha 3 | 564 |
| 17:78389846–78390246 | ENDOV | endonuclease V | 577 |
| 3:101231200–101231600 | SENP7 | SUMO1/sentrin specific peptidase 7 | 628 |
| 13:28673851–28674251 | FLT3 | fms-related tyrosine kinase 3 | 656 |
| 18:32919753–32920153 | ZNF24 | zinc finger protein 24 | 665 |
| 2:202644765–202645165 | ALS2 | amyotrophic lateral sclerosis 2 (juvenile) | 680 |
| 17:17183036–17183436 | COPS3 | COP9 constitutive photomorphogenic homolog subunit 3 (Arabidopsis) | 778 |
| 19:12661227–12661627 | ZNF564 | zinc finger protein 564 | 821 |
| 8:107283104–107283504 | OXR1 | oxidation resistance 1 | 831 |
| 2:25390345–25390745 | POMC | proopiomelanocortin | 895 |
| 3:192959642–192960042 | HRASLS | HRAS-like suppressor | 928 |
| 19:54662449–54662849 | LENG1 | leukocyte receptor cluster (LRC) member 1 | 971 |
| 12:100595414–100595814 | ACTR6 | ARP6 actin-related protein 6 homolog (yeast) | 985 |
| 13:27828691–27829091 | RPL21 | ribosomal protein L21 | 1049 |
| 12:57858360–57858760 | GLI1 | GLI family zinc finger 1 | 1085 |
| 17:74476687–74477087 | RHBDF2 | rhomboid 5 homolog 2 (Drosophila) | 1089 |
| 19:38712475–38712875 | DPF1 | D4, zinc and double PHD fingers family 1 | 1138 |
| 19:53138925–53139325 | ZNF83 | zinc finger protein 83 | 1214 |
| 9:6644198–6644598 | GLDC | glycine dehydrogenase (decarboxylating) | 1252 |
| 3:172362558–172362958 | AC007919.2 | HCG1787166; PRO1163 | 1275 |
| 17:71230451–71230851 | C17orf80 | chromosome 17 open reading frame 80 | 1286 |
| 12:123875689–123876089 | SETD8 | SET domain containing (lysine methyltransferase) 8 | 1300 |
| 7:98479823–98480223 | TRRAP | transformation/transcription domain-associated protein | 1310 |
| 7:72396789–72397189 | POM121 | POM121 transmembrane nucleoporin | 1329 |
| 4:187646331–187646731 | FAT1 | FAT tumor suppressor homolog 1 (Drosophila) | 1345 |
| 2:216256316–216256716 | FN1 | fibronectin 1 | 1354 |
| 17:40654447–40654847 | ATP6V0A1 | ATPase, H+ transporting, lysosomal V0 subunit a1 | 1387 |
| 12:111857341–111857741 | SH2B3 | SH2B adaptor protein 3 | 1397 |
| 12:110925896–110926296 | FAM216A | family with sequence similarity 216, member A | 1400 |
| 2:53996217–53996617 | CHAC2 | ChaC, cation transport regulator homolog 2 (E. coli) | 1488 |
| 2:947917–948317 | SNTG2 | syntrophin, gamma 2 | 1492 |
Genome annotation Summary.
The number of genomic features such as CpG islands, CpG shores, ENSEMBL Genes and DNA Repeats (LINE, SINE and LTR) associated with regions undergoing gain-of-5mC/5hmC and loss-of-5mC/5hmC DMRs or DHMRs in TK6 cells cultured under simulated microgravity compared to static condition.
| Features | DMR | DHMR | ||
|---|---|---|---|---|
| Gain-of-5mC | Loss-of-5mC | Gain-of-5hmC | Loss-of-5hmC | |
| 23 | 69 | 1 | 0 | |
| 127 | 277 | 5 | 1 | |
| 969 | 1381 | 86 | 7 | |
| 421 | 521 | 47 | 1 | |
| 944 | 1973 | 18 | 11 | |
| 157 | 227 | 28 | 0 | |
List of hypomethylated DMRs located within +/- 1500 of Transcription Start Sites of genes.
Columns display the genomic coordinates of DMRs, Gene Symbol of the corresponding gene, the description of the genome and the exact distance in base pairs.
| DMR (Chr:Start-End) | Gene Symbol | Description | Distance |
|---|---|---|---|
| 1:45958152–45958568 | TESK2 | testis-specific kinase 2 | -1488 |
| 13:21138922–21139338 | IFT88 | intraflagellar transport 88 homolog (Chlamydomonas) | -1455 |
| 12:6831258–6831674 | COPS7A | COP9 constitutive photomorphogenic homolog subunit 7A (Arabidopsis) | -1441 |
| 11:107990630–107991046 | ACAT1 | acetyl-CoA acetyltransferase 1 | -1405 |
| 19:569701–570117 | BSG | basigin (Ok blood group) | -1388 |
| 19:54664797–54665213 | LENG1 | leukocyte receptor cluster (LRC) member 1 | -1385 |
| 14:50232737–50233153 | KLHDC2 | kelch domain containing 2 | -1381 |
| 11:47289128–47289544 | MADD | MAP-kinase activating death domain | -1376 |
| 17:33465350–33465766 | NLE1 | notchless homolog 1 (Drosophila) | -1372 |
| 2:72372691–72373107 | CYP26B1 | cytochrome P450, family 26, subfamily B, polypeptide 1 | -1355 |
| 20:34543689–34544105 | SCAND1 | SCAN domain containing 1 | -1349 |
| 8:76318743–76319159 | HNF4G | hepatocyte nuclear factor 4, gamma | -1320 |
| 17:48946441–48946857 | TOB1 | transducer of ERBB2, 1 | -1310 |
| 16:3931818–3932234 | CREBBP | CREB binding protein | -1299 |
| 2:211306550–211306966 | LANCL1 | LanC lantibiotic synthetase component C-like 1 (bacterial) | -1289 |
| 1:47780891–47781307 | STIL | SCL/TAL1 interrupting locus | -1280 |
| 17:16333898–16334314 | TRPV2 | transient receptor potential cation channel, subfamily V, member 2 | -1263 |
| 3:12706770–12707186 | RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | -1253 |
| 19:49577242–49577658 | KCNA7 | potassium voltage-gated channel, shaker-related subfamily, member 7 | -1252 |
| 5:175974933–175975349 | CDHR2 | cadherin-related family member 2 | -1251 |
| 5:156363707–156364123 | TIMD4 | T-cell immunoglobulin and mucin domain containing 4 | -1228 |
| 12:49111699–49112115 | CCNT1 | cyclin T1 | -1226 |
| 17:79607945–79608361 | TSPAN10 | tetraspanin 10 | -1196 |
| 1:25257327–25257743 | RUNX3 | runt-related transcription factor 3 | -1167 |
| 12:110460055–110460471 | ANKRD13A | ankyrin repeat domain 13A | -1161 |
| 22:43011912–43012328 | POLDIP3 | polymerase (DNA-directed), delta interacting protein 3 | -1152 |
| 13:52981570–52981986 | THSD1 | thrombospondin, type I, domain containing 1 | -1149 |
| 9:103203198–103203614 | MSANTD3-TMEFF1 | MSANTD3-TMEFF1 readthrough | -1147 |
| 9:123584680–123585096 | PSMD5 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 5 | -1144 |
| 19:10827435–10827851 | DNM2 | dynamin 2 | -1112 |
| 1:32404887–32405303 | PTP4A2 | protein tyrosine phosphatase type IVA, member 2 | -1107 |
| 2:203129141–203129557 | NOP58 | NOP58 ribonucleoprotein | -1090 |
| 12:53474061–53474477 | SPRYD3 | SPRY domain containing 3 | -1065 |
| 4:87814423–87814839 | C4orf36 | chromosome 4 open reading frame 36 | -1062 |
| 17:29157723–29158139 | ATAD5 | ATPase family, AAA domain containing 5 | -1057 |
| 19:50029617–50030033 | RCN3 | reticulocalbin 3, EF-hand calcium binding domain | -1050 |
| 9:19150115–19150531 | PLIN2 | perilipin 2 | -1047 |
| 7:138666899–138667315 | KIAA1549 | KIAA1549 | -1043 |
| 11:66446181–66446597 | RBM4B | RNA binding motif protein 4B | -997 |
| 16:88783445–88783861 | PIEZO1 | piezo-type mechanosensitive ion channel component 1 | -968 |
| 5:176828391–176828807 | PFN3 | profilin 3 | -962 |
| 6:35309180–35309596 | PPARD | peroxisome proliferator-activated receptor delta | -947 |
| 3:52805678–52806094 | NEK4 | NIMA-related kinase 4 | -921 |
| 14:52291822–52292238 | GNG2 | guanine nucleotide binding protein (G protein), gamma 2 | -883 |
| 1:150292846–150293262 | PRPF3 | PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae) | -871 |
| 1:28560198–28560614 | DNAJC8 | DnaJ (Hsp40) homolog, subfamily C, member 8 | -870 |
| 17:1626772–1627188 | WDR81 | WD repeat domain 81 | -854 |
| 16:72137332–72137748 | DHX38 | DEAH (Asp-Glu-Ala-His) box polypeptide 38 | -845 |
| 18:77961381–77961797 | PARD6G | par-6 partitioning defective 6 homolog gamma (C. elegans) | -825 |
| 13:42621863–42622279 | DGKH | diacylglycerol kinase, eta | -818 |
| 13:77461149–77461565 | KCTD12 | potassium channel tetramerisation domain containing 12 | -817 |
| 22:43037207–43037623 | ATP5L2 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G2 | -808 |
| 15:42076825–42077241 | AC073657.1 | -804 | |
| 5:170189356–170189772 | GABRP | gamma-aminobutyric acid (GABA) A receptor, pi | -790 |
| 20:34000467–34000883 | UQCC | ubiquinol-cytochrome c reductase complex chaperone | -731 |
| 9:99802448–99802864 | CTSL2 | cathepsin L2 | -731 |
| 22:50766008–50766424 | DENND6B | DENN/MADD domain containing 6B | -727 |
| 22:19279757–19280173 | CLTCL1 | clathrin, heavy chain-like 1 | -726 |
| 1:154244054–154244470 | HAX1 | HCLS1 associated protein X-1 | -725 |
| 9:125591423–125591839 | PDCL | phosducin-like | -721 |
| 15:40401584–40402000 | BMF | Bcl2 modifying factor | -699 |
| 12:48745657–48746073 | ZNF641 | zinc finger protein 641 | -668 |
| 1:107598393–107598809 | PRMT6 | protein arginine methyltransferase 6 | -666 |
| 5:134073321–134073737 | CAMLG | calcium modulating ligand | -662 |
| 19:2256862–2257278 | JSRP1 | junctional sarcoplasmic reticulum protein 1 | -654 |
| 4:17783579–17783995 | FAM184B | family with sequence similarity 184, member B | -652 |
| 6:25965887–25966303 | TRIM38 | tripartite motif containing 38 | -649 |
| 2:242186700–242187116 | HDLBP | high density lipoprotein binding protein | -629 |
| 7:43909561–43909977 | MRPS24 | mitochondrial ribosomal protein S24 | -613 |
| 20:44440411–44440827 | UBE2C | ubiquitin-conjugating enzyme E2C | -596 |
| 8:99075748–99076164 | C8orf47 | chromosome 8 open reading frame 47 | -583 |
| 8:19680112–19680528 | INTS10 | integrator complex subunit 10 | -579 |
| 15:60885693–60886109 | RORA | RAR-related orphan receptor A | -576 |
| 9:124856243–124856659 | TTLL11 | tubulin tyrosine ligase-like family, member 11 | -566 |
| 12:123948281–123948697 | SNRNP35 | small nuclear ribonucleoprotein 35kDa (U11/U12) | -564 |
| 4:190861171–190861587 | FRG1 | FSHD region gene 1 | -564 |
| 19:11450690–11451106 | RAB3D | RAB3D, member RAS oncogene family | -554 |
| 10:126489606–126490022 | FAM175B | family with sequence similarity 175, member B | -540 |
| 7:129691616–129692032 | ZC3HC1 | zinc finger, C3HC-type containing 1 | -533 |
| 13:103458965–103459381 | RP11-484I6.7 | BIVM-ERCC5 protein | -531 |
| 22:30475426–30475842 | HORMAD2 | HORMA domain containing 2 | -529 |
| 3:155463174–155463590 | PLCH1 | phospholipase C, eta 1 | -526 |
| 19:39970330–39970746 | TIMM50 | translocase of inner mitochondrial membrane 50 homolog (S. cerevisiae) | -514 |
| 19:56347244–56347660 | NLRP4 | NLR family, pyrin domain containing 4 | -492 |
| 1:26871647–26872063 | RPS6KA1 | ribosomal protein S6 kinase, 90kDa, polypeptide 1 | -488 |
| 11:62555950–62556366 | TMEM179B | transmembrane protein 179B | -483 |
| 19:2740422–2740838 | SLC39A3 | solute carrier family 39 (zinc transporter), member 3 | -480 |
| 8:146176515–146176931 | ZNF16 | zinc finger protein 16 | -449 |
| 2:175202383–175202799 | AC018470.1 | Uncharacterized protein FLJ46347 | -440 |
| 3:141120576–141120992 | ZBTB38 | zinc finger and BTB domain containing 38 | -407 |
| 1:27213196–27213612 | GPN2 | GPN-loop GTPase 2 | -388 |
| 19:12946378–12946794 | RTBDN | retbindin | -344 |
| 10:28032598–28033014 | MKX | mohawk homeobox | -332 |
| 6:44923360–44923776 | SUPT3H | suppressor of Ty 3 homolog (S. cerevisiae) | -321 |
| 21:34926838–34927254 | SON | SON DNA binding protein | -309 |
| 20:4880379–4880795 | SLC23A2 | solute carrier family 23 (nucleobase transporters), member 2 | -294 |
| 21:45078094–45078510 | HSF2BP | heat shock transcription factor 2 binding protein | -277 |
| 13:50070769–50071185 | PHF11 | PHD finger protein 11 | -272 |
| 16:22018485–22018901 | C16orf52 | chromosome 16 open reading frame 52 | -266 |
| 11:17372825–17373241 | NCR3LG1 | natural killer cell cytotoxicity receptor 3 ligand 1 | -240 |
| 20:36149179–36149595 | NNAT | neuronatin | -230 |
| 14:96670598–96671014 | BDKRB2 | bradykinin receptor B2 | -210 |
| 6:84419386–84419802 | SNAP91 | synaptosomal-associated protein, 91kDa | -184 |
| 17:57983959–57984375 | RPS6KB1 | ribosomal protein S6 kinase, 70kDa, polypeptide 1 | -182 |
| 9:130660260–130660676 | ST6GALNAC6 | ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 | -177 |
| 1:107683060–107683476 | NTNG1 | netrin G1 | -174 |
| 18:2846660–2847076 | EMILIN2 | elastin microfibril interfacer 2 | -160 |
| 17:73528230–73528646 | LLGL2 | lethal giant larvae homolog 2 (Drosophila) | -136 |
| 3:55521255–55521671 | WNT5A | wingless-type MMTV integration site family, member 5A | -132 |
| 4:99578749–99579165 | TSPAN5 | tetraspanin 5 | -114 |
| 17:72580766–72581182 | C17orf77 | chromosome 17 open reading frame 77 | -83 |
| 17:73085977–73086393 | SLC16A5 | solute carrier family 16, member 5 (monocarboxylic acid transporter 6) | -72 |
| 11:62445317–62445733 | UBXN1 | UBX domain protein 1 | -70 |
| 2:219906078–219906494 | CCDC108 | coiled-coil domain containing 108 | -41 |
| 1:47697216–47697632 | TAL1 | T-cell acute lymphocytic leukemia 1 | -37 |
| 17:73230571–73230987 | NUP85 | nucleoporin 85kDa | -20 |
| 4:111397002–111397418 | ENPEP | glutamyl aminopeptidase (aminopeptidase A) | -19 |
| 19:11658471–11658887 | CNN1 | calponin 1, basic, smooth muscle | 24 |
| 4:47839834–47840250 | CORIN | corin, serine peptidase | 47 |
| 15:55790255–55790671 | DYX1C1 | dyslexia susceptibility 1 candidate 1 | 83 |
| 21:34924435–34924851 | SON | SON DNA binding protein | 89 |
| 15:57025972–57026388 | ZNF280D | zinc finger protein 280D | 104 |
| 6:137815204–137815620 | OLIG3 | oligodendrocyte transcription factor 3 | 119 |
| 14:23652505–23652921 | SLC7A8 | solute carrier family 7 (amino acid transporter light chain, L system), member 8 | 136 |
| 12:31812613–31813029 | METTL20 | methyltransferase like 20 | 176 |
| 14:72400014–72400430 | RGS6 | regulator of G-protein signaling 6 | 273 |
| 2:98703769–98704185 | VWA3B | von Willebrand factor A domain containing 3B | 278 |
| 3:186281629–186282045 | TBCCD1 | TBCC domain containing 1 | 297 |
| 6:43112135–43112551 | PTK7 | PTK7 protein tyrosine kinase 7 | 306 |
| 14:64956734–64957150 | ZBTB25 | zinc finger and BTB domain containing 25 | 309 |
| 2:216239872–216240288 | FN1 | fibronectin 1 | 332 |
| 19:14217131–14217547 | PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 333 |
| 20:62903727–62904143 | PCMTD2 | protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2 | 385 |
| 14:32545502–32545918 | ARHGAP5 | Rho GTPase activating protein 5 | 390 |
| 2:24271847–24272263 | C2orf44 | chromosome 2 open reading frame 44 | 390 |
| 11:63754509–63754925 | OTUB1 | OTU domain, ubiquitin aldehyde binding 1 | 403 |
| 3:188665201–188665617 | TPRG1 | tumor protein p63 regulated 1 | 406 |
| 5:96294368–96294784 | LNPEP | leucyl/cystinyl aminopeptidase | 421 |
| 1:151694242–151694658 | RIIAD1 | regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1 | 437 |
| 19:16204630–16205046 | TPM4 | tropomyosin 4 | 456 |
| 11:71163246–71163662 | DHCR7 | 7-dehydrocholesterol reductase | 460 |
| 12:3120506–3120922 | TEAD4 | TEA domain family member 4 | 504 |
| 1:200012019–200012435 | NR5A2 | nuclear receptor subfamily 5, group A, member 2 | 510 |
| 19:6007516–6007932 | RFX2 | regulatory factor X, 2 (influences HLA class II expression) | 513 |
| 2:216300012–216300428 | FN1 | fibronectin 1 | 570 |
| 16:57474089–57474505 | CIAPIN1 | cytokine induced apoptosis inhibitor 1 | 590 |
| 3:42002666–42003082 | ULK4 | unc-51-like kinase 4 (C. elegans) | 612 |
| 1:228644735–228645151 | HIST3H2A | histone cluster 3, H2a | 617 |
| 19:47735191–47735607 | BBC3 | BCL2 binding component 3 | 624 |
| 13:36919583–36919999 | SPG20 | spastic paraplegia 20 (Troyer syndrome) | 629 |
| 22:30477422–30477838 | HORMAD2 | HORMA domain containing 2 | 630 |
| 2:235404366–235404782 | ARL4C | ADP-ribosylation factor-like 4C | 670 |
| 10:7860937–7861353 | TAF3 | TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 140kDa | 678 |
| 12:58160138–58160554 | CYP27B1 | cytochrome P450, family 27, subfamily B, polypeptide 1 | 688 |
| 6:35420636–35421052 | FANCE | Fanconi anemia, complementation group E | 706 |
| 19:13988601–13989017 | NANOS3 | nanos homolog 3 (Drosophila) | 746 |
| 10:74870845–74871261 | NUDT13 | nudix (nucleoside diphosphate linked moiety X)-type motif 13 | 765 |
| 6:27115481–27115897 | HIST1H2AH | histone cluster 1, H2ah | 828 |
| 1:247266524–247266940 | ZNF669 | zinc finger protein 669 | 848 |
| 19:47216200–47216616 | PRKD2 | protein kinase D2 | 872 |
| 14:21946061–21946477 | TOX4 | TOX high mobility group box family member 4 | 886 |
| 19:11668857–11669273 | ELOF1 | elongation factor 1 homolog (S. cerevisiae) | 895 |
| 17:36996603–36997019 | C17orf98 | chromosome 17 open reading frame 98 | 897 |
| 20:31123045–31123461 | C20orf112 | chromosome 20 open reading frame 112 | 947 |
| 12:50786921–50787337 | LARP4 | La ribonucleoprotein domain family, member 4 | 963 |
| 20:62340208–62340624 | ZGPAT | zinc finger, CCCH-type with G patch domain | 974 |
| 6:44188171–44188587 | SLC29A1 | solute carrier family 29 (nucleoside transporters), member 1 | 986 |
| 3:185001603–185002019 | MAP3K13 | mitogen-activated protein kinase kinase kinase 13 | 997 |
| 12:65089089–65089505 | AC025262.1 | Mesenchymal stem cell protein DSC96 | 1032 |
| 9:19050250–19050666 | RRAGA | Ras-related GTP binding A | 1086 |
| 16:1878116–1878532 | FAHD1 | fumarylacetoacetate hydrolase domain containing 1 | 1099 |
| 1:35323305–35323721 | SMIM12 | small integral membrane protein 12 | 1133 |
| 20:62461205–62461621 | ZBTB46 | zinc finger and BTB domain containing 46 | 1154 |
| 19:17531871–17532287 | MVB12A | multivesicular body subunit 12A | 1159 |
| 11:638254–638670 | DRD4 | dopamine receptor D4 | 1169 |
| 15:79576111–79576527 | ANKRD34C | ankyrin repeat domain 34C | 1173 |
| 3:55519903–55520319 | WNT5A | wingless-type MMTV integration site family, member 5A | 1220 |
| 7:148786349–148786765 | ZNF786 | zinc finger protein 786 | 1240 |
| 19:39437782–39438198 | FBXO17 | F-box protein 17 | 1253 |
| 19:47352074–47352490 | AP2S1 | adaptor-related protein complex 2, sigma 1 subunit | 1291 |
| 2:201751795–201752211 | PPIL3 | peptidylprolyl isomerase (cyclophilin)-like 3 | 1299 |
| 12:92529288–92529704 | RP11-24B21.1 | uncharacterized protein LOC256021 isoform 1 | 1301 |
| 1:152007979–152008395 | S100A11 | S100 calcium binding protein A11 | 1324 |
| 13:103424546–103424962 | TEX30 | testis expressed 30 | 1351 |
| 6:107779175–107779591 | PDSS2 | prenyl (decaprenyl) diphosphate synthase, subunit 2 | 1377 |
| 1:31380013–31380429 | SDC3 | syndecan 3 | 1387 |
| 22:31004379–31004795 | TCN2 | transcobalamin II | 1396 |
| 20:44423810–44424226 | DNTTIP1 | deoxynucleotidyltransferase, terminal, interacting protein 1 | 1414 |
| 19:46086441–46086857 | OPA3 | optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia) | 1428 |
| 3:160115349–160115765 | IFT80 | intraflagellar transport 80 homolog (Chlamydomonas) | 1438 |
| 14:23282743–23283159 | SLC7A7 | solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 | 1440 |
| 18:686337–686753 | ENOSF1 | enolase superfamily member 1 | 1459 |
| 8:135650448–135650864 | ZFAT | zinc finger and AT hook domain containing | 1467 |
List of hyper-hydroxymethylated DHMRs located within +/- 1500 of Transcription Start Sites of genes.
Columns display the genomic coordinates of DHMRs, Gene Symbol of the corresponding gene, the description of the genome and the exact distance in base pairs.
| DHMR(Chr:Start-End) | Gene Symbol | Description | Distance |
|---|---|---|---|
| 7:73103920–73104390 | WBSCR22 | Williams Beuren syndrome chromosome region 22 | -1091 |
| 19:11319910–11320380 | DOCK6 | dedicator of cytokinesis 6 | -525 |
| 19:6678748–6679218 | C3 | complement component 3 | 229 |
| 20:29977639–29978109 | DEFB119 | defensin, beta 119 | 412 |
| 11:117745746–117746216 | FXYD6 | FXYD domain containing ion transport regulator 6 | 1359 |
List of hypo-hydroxymethylated DHMRs located within +/- 1500 of Transcription Start Sites of genes.
Columns display the genomic coordinates of DHMRs, Gene Symbol of the corresponding gene, the description of the genome and the exact distance in base pairs
| DHMR(Chr:Start-End) | Gene Symbol | Description | Distance |
|---|---|---|---|
| 3:96336458–96336934 | MTRNR2L2 | MT-RNR2-like 2 | -579 |
| 3:96336159–96336635 | MTRNR2L2 | MT-RNR2-like 2 | -280 |